Challenging Psychedelic Experiences Study & Compass' Phase III Trial Design
www.thetripreport.com
Greetings from NYC! I have just arrived for the Horizons Conference and looking forward to seeing many of you this weekend! Today’s dispatch is brief but looks at Compass Pathways’ announcement of the trial design and enrollment goals for the Phase III program for COMP360 (psilocybin) for Treatment-Resistant Depression.
Challenging Psychedelic Experiences Study & Compass' Phase III Trial Design
Challenging Psychedelic Experiences Study …
Challenging Psychedelic Experiences Study & Compass' Phase III Trial Design
Greetings from NYC! I have just arrived for the Horizons Conference and looking forward to seeing many of you this weekend! Today’s dispatch is brief but looks at Compass Pathways’ announcement of the trial design and enrollment goals for the Phase III program for COMP360 (psilocybin) for Treatment-Resistant Depression.